Skip to content

Evluation of Thyroid Functions in Hemodialysis Childern in Sohag University Hospital

Evalution of Thyroid Functions in Hemodialysis Children in Sohag University Hospital

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05451472
Enrollment
39
Registered
2022-07-11
Start date
2022-07-01
Completion date
2023-01-01
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Brief summary

Thyroid gland and its hormones play an important role in organ development and the homeostatic control of many physiological mechanisms such as body growth and energy expenditure. The two main thyroid hormones are triiodothyronine (T3) and thyroxine (T4) affect renal development and metabolism so any impairment in thyroid functions lead to or aggravate kidney diseases. On the other hand, kidneys play an important role in the thyroid metabolism as it normally contributes to the clearance of iodide, primarily by glomerular filtration. Among patients with renal failure, there is diminished iodide excretion and an increase in plasma inorganic iodide, which results in increased uptake of the iodide by the thyroid gland. Increases in total body inorganic iodide can potentially block thyroid hormone production (the Wolff-Chaik off effect). Such a change may explain the slightly higher frequency of goiter and hypothyroidism in patients with chronic kidney diseases. The kidneys affect the hypothalamic pituitary-thyroid axis, so any impairment in kidney functions leads to disturbed thyroid physiology. All levels of the hypothalamic-pituitary-thyroid axis may be involved, including alterations in hormone production, distribution, and excretion. End stage renal disease (ESRD) and hemodialysis (HD) affect the levels of all thyroid hormones. The earliest and the most common thyroid function abnormality in patients with ESRD on HD is low T3 level (especially total T3 than free T3). This is called 'low T3 syndrome. The prevalence of subclinical hypothyroidism has been reported to be much higher in patients with ESRD on HD than in the general population. Due to similarity of signs and symptoms, sometimes it is difficult to identify subjects with ESRD also has hypothyroidism; therefore, different studies have been carried out to establish the incidence of these conditions.

Interventions

DIAGNOSTIC_TESTthyroid function tests

Thyroid function tests:thyroid stimulating hormone (TSH), total thyroxine (T4), free thyroxine (FT4), total triiodothyronine (T3), and free triiodothyronine (FT3)

DIAGNOSTIC_TESTcomplete blood count

complete blood count

DIAGNOSTIC_TESTserum creatinine

serum creatinine

DIAGNOSTIC_TESTblood urea

blood urea

DIAGNOSTIC_TESTserum electrolyte

serum electrolyte

DIAGNOSTIC_TESTserum calcium

serum calcium

DIAGNOSTIC_TESTserum phosphorus

serum phosphorus

parathyroid hormone level

DIAGNOSTIC_TESTliver function test

ALT\_AST\_Total biliruin\_total protein \_serum albumin

DIAGNOSTIC_TESTarterial blood gases

PH\_PCO2\_PO2\_HCO3\_base deficit

DIAGNOSTIC_TESTcomplete urine analysis

complete urine analysis

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children started hemodialysis for end stage renal disease at age of 2 to 16 years will be included in the study.

Exclusion criteria

* Patients with known thyroid disease. Patients with a history of autoimmune disease .

Design outcomes

Primary

MeasureTime frameDescription
Detection of thyroid function in hemodialysis childern6 monthsDetection of decrease thyroid function(T3\_T4\_TSH) in hemodialysis childern Detection of increase thyroid function(T3\_T4\_TSH) in hemodialysis childern

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026